Cryogenic OGS H1FY27: consolidated PAT ₹7.37 Cr; standalone revenue +44% YoY, margins up
PAT +22.53% YoY · revenue +44.12% · margins expanding
₹40.1 Cr
+44.12% YoY
₹7.37 Cr
+22.53% YoY
18.04%
-7.4pp YoY
₹4.95
Cryogenic OGS's maiden consolidated financials — for the half year ended 30 September 2026 (H1 FY27), its first filing with the Precision Engineering Products subsidiary folded in — show consolidated revenue of ₹40.10 Cr and consolidated PAT of ₹7.37 Cr (₹7.07 Cr to owners, ₹0.30 Cr to minority interest), EPS ₹4.95. Because the subsidiary became one only this period, there is no consolidated year-ago base; the only like-for-like comparison is standalone, where revenue rose 44.1% YoY to ₹30.36 Cr and reported PAT rose 22.5% YoY to ₹6.76 Cr. The company carries zero sell-side coverage (0 analysts per SimplyWall St), so there is no street consensus to beat or miss. Management's own prior concall commentary had flagged expectations of 'good orders of similar size in H1 FY27 and through FY27'; order wins through the half (a ₹5.07 Cr international MNC order on Sep 30, a $2.02M piping-spools export order on Sep 18, a ₹4.6 Cr gas-metering-skids order on Aug 20) plus fresh ADNOC vendor approval and IBR certification for piping spools/strainers (Oct 8, just after period-end) indicate that pipeline materialised — the quarter reads as broadly meeting that loosely-worded guidance, though no numeric target exists in our records to grade precisely.
Q2 FY-2027 vs prior quarters
Reported standalone PAT growth of 22.5% looks modest against 44% revenue growth, but that is a base-period artefact: H1 FY26 PAT was lifted by a ₹1.24 Cr one-off profit on sale of plot that has no equivalent this period. Stripping that one-off from both sides, adjusted PAT growth is closer to +58%, and adjusted net margin actually expands from ~19.7% to 21.65% — consistent with operating margin (EBITDA/revenue) expanding from ~30.0% to ~32.4% on cost discipline (materials cost ratio eased) and operating leverage. Headline NPM nonetheless fell from 25.41% to 21.65% purely on that lost one-off, compounded by a sharp jump in standalone finance costs (₹0.02 Cr to ₹0.27 Cr) as lease liabilities rose to ₹8.40 Cr and the company advanced a ₹6.18 Cr loan to its subsidiary. That lease-driven finance-cost line is worth flagging against the company's public zero-debt positioning, since it is now a visible, growing P&L item even without conventional borrowings.
The stock went into the print at ₹393, down 9.8% over the past month of trading.
W1
Trajectory of lease-funded finance costs (₹8.40 Cr lease liabilities) against the company's zero-debt positioning in H2 FY27
W2
H2 FY27 will provide the first true consolidated YoY base once the Precision Engineering Products subsidiary has a full prior-period comparator
W3
Conversion of the Oct 8, 2026 ADNOC vendor approval and IBR certification into booked orders/revenue in H2 FY27
Filing is HALF-YEARLY (H1 FY27, half year ended 30-09-2026), not quarterly — company reports only standalone & consolidated half-yearly results, so no discrete Q2 figures exist; source amounts are in ₹ Lakh (confirmed via the consolidated page's explicit 'Rs in Lakhs' header and by cross-checking against our DB's 'year-ago quarter' record, which is itself H1 FY26 half-year data: EPS 4.52 and PAT ₹5.517 Cr = 551.67 Lakh match the PDF's H1 FY26 column exactly). Consolidated statement carries no prior-period comparative because the Precision Engineering Products subsidiary was consolidated for the first time this period (company note). Standalone PAT YoY is distorted by a ₹1.24 Cr one-off 'profit on sale of plot' in the H1 FY26 base (none this period); adjusted PAT YoY is ~+58% vs raw +22.5%. Consolidated PAT of ₹7.37 Cr splits ₹7.07 Cr to owners and ₹0.30 Cr to minority interest.